Inogen | INGN - Ebitda


Inogen reported $-9.42M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
AngioDynamics USD -369K 2.01M Feb/2025
AtriCure USD 17.8M 2.45M Sep/2025
Baxter International USD 462M 137M Jun/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Chart Industries USD 277.1M 9.8M Sep/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
Dexcom USD 368.4M 59.6M Sep/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Globus Medical USD 252.6M 43.92M Sep/2025
Insulet USD 160M 2.5M Sep/2025
Masimo USD 72M 42.6M Jun/2025
Medtronic USD 2.44B 139M Sep/2025
Orthofix International USD 7.73M 7.64M Sep/2024
Philips EUR 738M 9M Sep/2025
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 389.7M 22.5M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 2.77M 4.62M Sep/2025
Teleflex USD 207.62M 15.28M Jun/2025
X T L Biopharmaceuticals USD -479K 19K Dec/2024
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025